UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence of human papillomavirus, cervical dysplasia and cervical cancer among women in Liberia: Assessing the burden of disease

Gynecologic oncology, 2015-04, Vol.137, p.70-70

2015

Volltextzugriff (PDF)

Patterns of care for FIGO stage IB-IIA cervical cancer across the United States

Gynecologic oncology, 2017-06, Vol.145, p.181-181

2017

Volltextzugriff (PDF)

Thirty-day hospital readmission and mortality in advanced ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.158-158

2017

Volltextzugriff (PDF)

Thirty-day hospital readmission and mortality in advanced uterine cancer

Gynecologic oncology, 2017-06, Vol.145, p.142-143

2017

Volltextzugriff (PDF)

Does use of uterine manipulator alter the rate of lymphovascular space invasion in patients with invasive cervical cancer undergoing radical hysterectomy?

Gynecologic oncology, 2015-04, Vol.137, p.145-145

2015

Volltextzugriff (PDF)

The addition of chemotherapy to adjuvant radiotherapy in patients with intermediate-risk stage IB cervical cancer and the effect on survival

Gynecologic oncology, 2017-06, Vol.145, p.134-134

2017

Volltextzugriff (PDF)

Establishment and combined genomic and proteomic characterization of patient-derived ovarian cancer cell lines

Gynecologic oncology, 2014-06, Vol.133, p.125-125

2014

Volltextzugriff (PDF)

Survey of current practice patterns in the treatment of early stage endometrial cancer among SGO members

Gynecologic oncology, 2015-04, Vol.137, p.150-150

2015

Volltextzugriff (PDF)

Surgical, pathologic and survival outcomes of patients undergoing open, laparoscopic or robotic radical hysterectomy for invasive cervical cancer

Gynecologic oncology, 2015-04, Vol.137, p.144-145

2015

Volltextzugriff (PDF)

Mutation profiling of uterine lavage fluid detects early-stage endometrial cancers and discovers a prevalent landscape of driver mutations in women without cancer

Gynecologic oncology, 2017-06, Vol.145, p.126-126

2017

Volltextzugriff (PDF)

Training Health Workers to Provide Cervical Cancer Screening: Comparison of Educational Strategies in Liberia, South Africa and Grenada

Annals of global health, 2017-04, Vol.83 (1), p.53-54

2017

Volltextzugriff (PDF)

A pre-operative, diagnostic gene panel for guiding primary treatment choices in endometrial cancer: Advancing beyond the decades-old technology of dilation and curettage (D&C)

European journal of cancer (1990), 2016-07, Vol.61, p.S33-S33

2016

Volltextzugriff (PDF)

869: Transcriptome and pathway analysis identifies IRF1 as a predictor of progression free and overall survival in ovarian carcinoma

European journal of cancer (1990), 2014-07, Vol.50, p.S213-S213

2014

Volltextzugriff (PDF)

Role of laparoscopy in determining optimal cytoreduction in patients with ovarian, fallopian tube and primary peritoneal cancer

Gynecologic oncology, 2015-04, Vol.137, p.103-103

2015

Volltextzugriff (PDF)

Personalized circulating tumor DNA biomarkers dynamically predict treatment response and survival in gynecologic cancers

Gynecologic oncology, 2016-06, Vol.141, p.3-4

2016

Volltextzugriff (PDF)

Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation

International journal of gynecological cancer, 2008-11, Vol.18 (6), p.1364-1367

2008

Volltextzugriff (PDF)

The tumor suppressor KLF6, lost in a majority of ovarian cancer cases, represses VEGF expression levels

Gynecologic oncology, 2011-03, Vol.120, p.S57-S57

2011

Volltextzugriff (PDF)

Insulin-like growth factor binding protein-4 (IGFBP-4) tumor and serum levels are increased across all stages of epithelial ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S93-S94

2012

Volltextzugriff (PDF)

Follicle-stimulating hormone receptor expression analysis in serous ovarian tumors suggests a disease continuum from low malignant potential to low-grade carcinoma

Gynecologic oncology, 2012-03, Vol.125, p.S142-S142

2012

Volltextzugriff (PDF)

Role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S107-S107

2012

Volltextzugriff (PDF)

Sequential chemotherapy and radiation therapy for the adjuvant treatment of uterine papillary serous carcinoma

Gynecologic oncology, 2011-03, Vol.120, p.S94-S94

2011

Volltextzugriff (PDF)

Laparoscopic management of adnexal masses in premenopausal and postmenopausal women

Obstetrics and gynecology (New York. 1953), 1999-02, Vol.93 (2), p.223-228

1999

Volltextzugriff (PDF)

KLF6-SV1 is a novel uterine leiomyosarcoma gene: From transgenic mouse model to human disease

Gynecologic oncology, 2011-03, Vol.120, p.S8-S8

2011

Volltextzugriff (PDF)

RNASeq identifies germline and tumor-specific mutations in a hereditary cervical cancer syndrome: Successful proof-of-principle study for gynecologic cancer gene discovery

Gynecologic oncology, 2011-03, Vol.120, p.S60-S60

2011

Volltextzugriff (PDF)

Secondary cytoreduction for ovarian cancer following cisplatin therapy

Journal of clinical oncology, 1993-03, Vol.11 (3), p.434-439

1993

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

Humans
(50)
Female
(49)
Life Sciences & Biomedicine
(45)
Science & Technology
(45)
Biological And Medical Sciences
(40)
Medical Sciences
(40)
Middle Aged
(31)
Obstetrics & Gynecology
(30)
Adult
(26)
Oncology
(22)
Aged
(21)
Hematology, Oncology And Palliative Medicine
(21)
Obstetrics And Gynecology
(20)
Gynecology. Andrology. Obstetrics
(19)
Tumors
(19)
Female Genital Diseases
(16)
Ovarian Neoplasms - Drug Therapy
(11)
Ovarian Neoplasms - Pathology
(10)
Pharmacology. Drug Treatments
(10)
Antineoplastic Agents
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence of human papillomavirus, cervical dysplasia and cervical cancer among women in Liberia: Assessing the burden of disease

Patterns of care for FIGO stage IB-IIA cervical cancer across the United States

Thirty-day hospital readmission and mortality in advanced ovarian cancer

Thirty-day hospital readmission and mortality in advanced uterine cancer

Does use of uterine manipulator alter the rate of lymphovascular space invasion in patients with invasive cervical cancer undergoing radical hysterectomy?

The addition of chemotherapy to adjuvant radiotherapy in patients with intermediate-risk stage IB cervical cancer and the effect on survival

Establishment and combined genomic and proteomic characterization of patient-derived ovarian cancer cell lines

Survey of current practice patterns in the treatment of early stage endometrial cancer among SGO members

Surgical, pathologic and survival outcomes of patients undergoing open, laparoscopic or robotic radical hysterectomy for invasive cervical cancer

Mutation profiling of uterine lavage fluid detects early-stage endometrial cancers and discovers a prevalent landscape of driver mutations in women without cancer

Training Health Workers to Provide Cervical Cancer Screening: Comparison of Educational Strategies in Liberia, South Africa and Grenada

A pre-operative, diagnostic gene panel for guiding primary treatment choices in endometrial cancer: Advancing beyond the decades-old technology of dilation and curettage (D&C)

869: Transcriptome and pathway analysis identifies IRF1 as a predictor of progression free and overall survival in ovarian carcinoma

Role of laparoscopy in determining optimal cytoreduction in patients with ovarian, fallopian tube and primary peritoneal cancer

Personalized circulating tumor DNA biomarkers dynamically predict treatment response and survival in gynecologic cancers

Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation

The tumor suppressor KLF6, lost in a majority of ovarian cancer cases, represses VEGF expression levels

Insulin-like growth factor binding protein-4 (IGFBP-4) tumor and serum levels are increased across all stages of epithelial ovarian cancer

Follicle-stimulating hormone receptor expression analysis in serous ovarian tumors suggests a disease continuum from low malignant potential to low-grade carcinoma

Role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer

Sequential chemotherapy and radiation therapy for the adjuvant treatment of uterine papillary serous carcinoma

Laparoscopic management of adnexal masses in premenopausal and postmenopausal women

KLF6-SV1 is a novel uterine leiomyosarcoma gene: From transgenic mouse model to human disease

RNASeq identifies germline and tumor-specific mutations in a hereditary cervical cancer syndrome: Successful proof-of-principle study for gynecologic cancer gene discovery

Secondary cytoreduction for ovarian cancer following cisplatin therapy

Suchergebnisse filtern